Oncological treatment in Brazil: a gender and region are associated to starting the therapeutics
Introduction: Malignant neoplasms are a major public health problem, being the second leading cause of death in the world. In 2012, the Ministry of Health (BR) instituted Law No. 12,732, which grants cancer patients the right to obtain, from the anatomopathological diagnosis, access to the first tre...
Main Authors: | Isabelle Maria dos Anjos Chaves, Vitória Alice Alves de Oliveira, Davi Neri Araujo, Fernanda Freitas Lemos Lopes, Artur Trancoso Lopo de Queiroz, Maisa Almeida Silva, Alexandre Souza Queiroz, Lygia Accioly Tinoco, Kiyoshi Ferreira Fukutani |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de Radioterapia
2021-10-01
|
Series: | Brazilian Journal of Oncology |
Subjects: | |
Online Access: | http://www.brazilianjournalofoncology.com.br/details/142/en-US/oncological-treatment-in-brazil--a-gender-and-region-are-associated-to-starting-the-therapeutics |
Similar Items
-
Pharmaceutical equivalence of oncology products marketed in Brazil
by: Marcus Augusto Lyrio Traple, et al.
Published: (2013-12-01) -
Pharmaceutical equivalence of oncology products marketed in Brazil
by: Marcus Augusto Lyrio Traple, et al.
Published: (2013-10-01) -
Milademetan is a highly potent MDM2 inhibitor in Merkel cell carcinoma
by: Varsha Ananthapadmanabhan, et al.
Published: (2022-07-01) -
Identification of Wee1 as a target in combination with avapritinib for gastrointestinal stromal tumor treatment
by: Shuai Ye, et al.
Published: (2021-01-01) -
Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade
by: Arnab Ghosh, et al.
Published: (2022-09-01)